CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or ...

Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / ...

Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...

SARGODHA: In a major step towards reviving Punjab’s declining citrus sector, the Citrus Research Institute (CRI), Sargodha is ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...

ALIGARH, Feb. 5 -- Private Partnership (PPP) with Molecular Diagnostics and Therapy LLP to establish a state-of-the-art ...

Novel Quality Controls to Enable QC & Inter-Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences ...

Author Capital Partners ("Author Capital" or "AuthorCap"), a Chicago-based principal investment firm, in partnership with industry leader Chris Howlett, today announced that its platform, Vanta ...

Probius to develop AI-powered point-of-care screening technology, eliminating sample preparation requirements and ...

The rapid evolutionary dynamics of RNA viruses, driven by high mutation rates and the consequent formation of complex quasispecies populations, present a formidable obstacle to conventional molecular ...

Lucid's Q3 2025 showed 2,841 tests and $7.1 million in pro forma revenues billed, but only $1.2 million could be ...